The Global HPV and Pap Testing Market Is Witnessing High Growth Owing To the Increasing Incidence of Cancer Cases in the World

 

HPV is an abbreviation for human papillomavirus, a family of more than 150 viruses. Every HPV virus has a number or a type. HPVs are attracted to a specific cell type known as squamous epithelial cells, and the viruses can only live in these cells. Some human papillomaviruses can cause non-cancerous tumours, while others can cause cancer, including cancer of the cervix, vagina, vulva, anus, penis, and parts of the mouth and throat that are mostly made up of moist skin in the body. These HPVs are classified as mucosal because they invade living cells on mucosal surfaces. Cervical cancer can be prevented by detecting and treating abnormal cells that form in the cervix.

The HPV and Pap Testing Market looks for the virus (human papillomavirus) that can cause cervix cell changes. The Pap test (or Pap smear) looks for precancers, which are cell changes on the cervix that can progress to cervical cancer if not treated properly. Increased number of HPV cases worldwide, resulting in cervical cancer, the most common cancer. The disease is primarily caused by genital infection. Also, the aging population, particularly women, is more vulnerable to infections. These factors will propel the market forward.

Increased emphasis on the introduction of new tests for the early detection of cervical cancer, specifically primary HPV testing, is expected to provide significant growth opportunities. 

Some of the major factors driving the market for HPV test HPV and Pap Testing Market  are technological advancements, an increase in the number of cervical cancer screening programs, and the high incidence of cervical cancer. However, the Covid-19 outbreak and the implementation of stay-at-home restrictions around the world have severely reduced routine cancer screenings.

One of the key factors expected to drive the market for HPV and Pap Testing Market test over the forecast period is the rising demand for technologically advanced diagnostic procedures for screening cervical and vaginal cancers.

Key Players

Qiagen N.V., Abbott Laboratories, Becton, Dickinson & Company, Hologic, Inc., Quest Diagnostics, Femasys, Inc., Roche Diagnostics, Arbor Vita Corporation, Onco Health Corporation, Seegene, Inc. are key players in the global HPV testing and Pap test market.